Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Clinical trial NCT01068795 · COMPLETED

Trial details

NCT number: NCT01068795
Sponsor: HaEmek Medical Center, Israel
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Fetal Demise Fetal Growth Restriction Preeclampsia Abruptio Placentae Thromboembolism

Start date: 2009-07-01
Primary completion: 2015-01-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.